{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:45:33Z","timestamp":1768351533002,"version":"3.49.0"},"reference-count":17,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>We report a case of a woman in her early 20s who presented with chronic and refractory oro-oesophageal ulcers and significant weight loss. The common causes of refractory ulcers were ruled out. Biopsy from the oesophageal ulcers was suggestive of paraneoplastic pemphigus (PNP). The patient underwent a PET scan that revealed an incidental mass. PET-guided biopsy from the infrarenal mass was suggestive of unicentric Castleman disease (UCD). She was managed with local surgical resection, steroids and rituximab. The current case highlights that PNP can be the presenting manifestation of an underlying UCD. In addition, it also highlights the adjunctive role of rituximab in the management of UCD-associated PNP in patients with suboptimal response to steroids and surgical resection.<\/jats:p>","DOI":"10.1136\/bcr-2024-263275","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:35:18Z","timestamp":1740530118000},"page":"e263275","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Unicentric Castleman disease-associated paraneoplastic pemphigus successfully managed with surgical resection and rituximab"],"prefix":"10.1136","volume":"18","author":[{"given":"Sarabjeet","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-8589","authenticated-orcid":false,"given":"Amanjit","family":"Bal","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-9789","authenticated-orcid":false,"given":"Arihant","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025082704061081000_18.2.e263275.1","doi-asserted-by":"crossref","unstructured":"Dispenzieri A , Fajgenbaum DC . Overview of castleman disease. 2020. Available: http:\/\/ashpublications.org\/blood\/articlepdf\/135\/16\/1353\/1724198\/bloodbld2019000931c.pdf","DOI":"10.1182\/blood.2019000931"},{"key":"2025082704061081000_18.2.e263275.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2025082704061081000_18.2.e263275.3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15019"},{"key":"2025082704061081000_18.2.e263275.4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/rheumatology\/keac481","article-title":"Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis","volume":"62","author":"Gonz\u00e1lez Garc\u00eda","year":"2023","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025082704061081000_18.2.e263275.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman Disease","volume":"32","author":"Simpson","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025082704061081000_18.2.e263275.6","doi-asserted-by":"crossref","unstructured":"Guo M , Nong L , Wang M , et al . A real-world study on a large retrospective cohort of castleman disease from a single center. In Review [Preprint]. doi:10.21203\/rs.3.rs-1748759\/v1","DOI":"10.21203\/rs.3.rs-1748759\/v1"},{"key":"2025082704061081000_18.2.e263275.7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025082704061081000_18.2.e263275.8","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","article-title":"International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease","volume":"4","author":"van Rhee","year":"2020","journal-title":"Blood Adv"},{"key":"2025082704061081000_18.2.e263275.9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04992.x"},{"key":"2025082704061081000_18.2.e263275.10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.21037\/hbsn.2019.05.05","article-title":"Retrospective analysis of 45 cases of localized retroperitoneal Castleman disease from a single center","volume":"9","author":"Tang","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2025082704061081000_18.2.e263275.11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjh.18847","article-title":"Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease","volume":"202","author":"Dieudonn\u00e9","year":"2023","journal-title":"Br J Haematol"},{"key":"2025082704061081000_18.2.e263275.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70145-3"},{"key":"2025082704061081000_18.2.e263275.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00322.x"},{"key":"2025082704061081000_18.2.e263275.14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/JBM.S60514","article-title":"Update and new approaches in the treatment of Castleman disease","volume":"7","author":"Chan","year":"2016","journal-title":"J Blood Med"},{"key":"2025082704061081000_18.2.e263275.15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bjh.15921","article-title":"Treatment and outcome of Unicentric Castleman Disease: a retrospective analysis of 71 cases","volume":"186","author":"Boutboul","year":"2019","journal-title":"Br J Haematol"},{"key":"2025082704061081000_18.2.e263275.16","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0"},{"key":"2025082704061081000_18.2.e263275.17","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1111\/ijd.15528","article-title":"Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman\u2019s disease","volume":"60","author":"Viswanath","year":"2021","journal-title":"Int J Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:06:22Z","timestamp":1756292782000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bcr-2024-263275"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263275","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}